Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs The Coca-Cola Co K (KO) Price & Performance

Acadia Healthcare Company IncTrade
The Coca-Cola Co KTrade

Price performance (Past 24H)

Key statistics

Acadia Healthcare Company Inc vs The Coca-Cola Co K — how do they compare? Acadia Healthcare Company Inc trades at $31.83 (market cap $2.90B), while The Coca-Cola Co K trades at $87.08 (market cap $372.08B). The key difference: The Coca-Cola Co K is far larger — about 128.3× Acadia Healthcare Company Inc's market cap, and The Coca-Cola Co K pays a 2.45% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.

ACHCKO
Market Cap
$2.90B$372.08B
Sector
HealthConsumer Staples
52-Week High
$35.61$89.08
52-Week Low
$11.68$65.67
Enterprise Value
$5.29B$399.26B
Volume
14,630,257
Dividend Yield
2.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.14, down 2.01% today, with a neutral technical signal and mixed fundamentals. The company reported Q2 2026 EPS of $0.38, beating estimates, but maintains a net loss of -$1.10B for 2025. Analyst consensus is bullish with a $36.00 price target, though ongoing legal investigations and negative profit margins present headwinds. Cash flow from operations improved to $211M in 2026, supporting operational stability amid challenges.

The outlook for ACHC hinges on execution of its turnaround strategy and resolution of legal issues. Upside potential exists if EBITDA guidance improvements and admissions growth persist, but risks from litigation and sustained losses warrant caution. The stock's current valuation at a P/E of 19.82 and P/S of 0.84 may attract value investors if profitability recovers.

The Coca-Cola Co K

Coca-Cola (KO) trades at $87.27, up 0.46% today, with a bullish technical signal and consistent earnings beats. The company shows strong profitability with a 28.56% net margin and 44.23% ROE, supported by stable revenue growth to $47.94B in 2025. Recent news highlights institutional accumulation and dividend reliability, with the stock near key resistance at $87.

Outlook remains positive with a $95.83 consensus price target and 60% analyst buy ratings, though high valuation multiples (P/E 25.97) and debt levels pose risks. The stock offers steady income with a $0.53 quarterly dividend and growth potential from global demand trends, but faces headwinds from regional volatility and competitive pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About The Coca-Cola Co K

The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.

Read more on KO